• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication for adhd and Odd During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There aren't many studies on how long-term exposure may affect the pregnant fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental disorders like hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the advantages of using them against the risks to the foetus. Doctors don't have enough data to make unambiguous recommendations but they can provide information on the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy were not at a higher risk of fetal malformations or structural birth defects. Researchers conducted a large, population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy and those who had not. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure correct case classification and to minimize the possibility of bias.

The study of the researchers was not without its limitations. The researchers were not able to, in the first place to distinguish the effects caused by the medication from the disorder. This makes it difficult for researchers to determine whether the small associations observed among the groups that were exposed to the use of medication or if they were confounded by co-morbidities. The researchers did not examine long-term outcomes for the offspring.

The study revealed that infants whose mothers took ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who didn't take any medication during pregnancy or had stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an elevated risk of having a caesarean delivery or having a baby born with low Apgar score (less than 7). These risks did not appear to be affected by the type of medication that was used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both mother and child of continued treatment for the woman's disorder. Physicians should talk to their patients about this and try to help them improve coping with adhd without medication skills which could reduce the impact of her disorder in her daily life and relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to continue treatment or stop as more women are diagnosed with ADHD. Most of the time, these decisions are made in the absence of clear and authoritative evidence regardless, so doctors must weigh their knowledge, the experiences of other doctors, and what research suggests on the subject as well as their best judgment for each patient.

The issue of risk to the infant can be difficult to determine. Many of the studies on this subject are based on observational data rather than controlled research and their conclusions are often contradictory. In addition, most studies limit their analysis to live births, which can underestimate severe teratogenic effects that lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these shortcomings by analyzing the data from deceased and live births.

The conclusion is that while certain studies have demonstrated an association between ADHD medications and the possibility of certain birth defects, other studies have found no connection, and most studies demonstrate a neutral or slightly negative impact. Therefore, a careful risk/benefit assessment is required in every instance.

For a lot of women with ADHD and ADD, the decision to stop taking medication is difficult if not impossible. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of isolation. A loss of medication may affect the ability to safely drive and perform work-related tasks, which are vital aspects of daily life for those with ADHD.

She suggests that women who are not sure whether to continue taking medication or stop it due to their pregnancy, educate their family members, coworkers, and friends about the condition, its effects on daily functioning, and the benefits of keeping the current treatment. It can also help a woman feel more confident in her decision. Certain medications can pass through the placenta. If the patient decides to not take her ADHD medication while breastfeeding, it is crucial to be aware that the medication may be transferred to her infant.

Risk of Birth Defects

As the use and use of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD), increases as does the concern about the potential effects of these drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. With two massive data sets, researchers were able to look at more than 4.3 million pregnancies and determine whether stimulant medication use increased the risk of birth defects. While the overall risk remains low, the scientists found that exposure in the first trimester to ADHD medications was associated with a slightly higher rate of specific heart defects, like ventriculo-septal defects (VSD).

The researchers behind the study found no link between the use of early medications and congenital abnormalities like facial clefting, or club foot. The results are consistent with previous studies that have shown an increase, but not significant, in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the birth of their child. The risk increased in the latter part of pregnancy when many women decided to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely to need a caesarean, have an insufficient Apgar after delivery, and had a baby that required breathing assistance at birth. The researchers of the study could not eliminate bias due to selection because they limited their study to women who did not have any other medical conditions that could have contributed to the findings.

The researchers hope their research will serve to inform the clinical decisions of physicians who treat pregnant women. The researchers recommend that while discussing the risks and benefits are important, the decision on whether to continue or stop medication should be made according to the severity of each woman's ADHD symptoms and her needs.

The authors also caution that, while stopping the medication is an option, it is not an option that is recommended due to the high prevalence of depression and other mental health issues among women who are pregnant or recently postpartum. Additionally, research suggests that women who stop taking their medication will have a difficult time adjusting to a life without them once the baby is born.

Nursing

It can be a challenge becoming a mother. Women who suffer from ADHD may face a lot of challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to a new routine. This is why many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk in low amounts. The rate of medication exposure will differ based on dosage and frequency of administration as well as the time of day. Additionally, different drugs enter the infant's system through the gastrointestinal tract or breast milk. The impact of these medications on the health of a newborn is not completely known.

Because of the lack of research, some physicians may recommend stopping stimulant drugs during a woman's pregnancy. This is a difficult choice for the patient, who must weigh the benefits of keeping her medication against the potential dangers to the foetus. Until more information is available, doctors should ask all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue taking their ADHD medication safely during pregnancy and while breast-feeding. As a result, an increasing number of patients choose to do so and, after consulting with their doctor, they have found that the benefits of maintaining their current medication exceed any risk.

It's important for women with adhd otc medication who are considering breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their physician and discuss the pros and cons of continued treatment, including non prescription adhd medication uk-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of the symptoms and the underlying disorder. They should also be educated about treatment options and reinforce strategies for coping. This should be a multidisciplinary process dealing with adhd without medication the GPs, obstetricians, and psychiatrists. Counselling for pregnancy should include discussion of a management plan for both the mother and child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.